Evidence map›Paper›PMID 17030608›Full record

ArticleMolecular and cellular biology2006

BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites.

Don Benjamin, Martin Schmidlin, Lu Min, Brigitte Gross, Christoph Moroni

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. 1-L Transcription in Prion Diseases.International journal of molecular sciences · 2024
    Article
  5. Article
  6. The Emerging Role of Stress Granules in Hepatocellular Carcinoma.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Review
  9. RNA-Binding Proteins in Acute Leukemias.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer.Oxidative medicine and cellular longevity · 2019
    Review
  13. Review
  14. Cell cycle RNA regulons coordinating early lymphocyte development.Wiley interdisciplinary reviews. RNA · 2017
    Review
  15. Article
  16. Review
  17. RNA binding proteins as regulators of immune cell biology.Clinical and experimental immunology · 2016
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Don BenjaminInstitute for Medical Microbiology, Petersplatz 10, 4003 Basel, Switzerland.
Martin Schmidlin
Lu Min
Brigitte Gross
Christoph Moroni

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BRF1 posttranscriptionally regulates mRNA levels by targeting ARE-bearing transcripts to the decay machinery. We previously showed that protein kinase B (PKB) phosphorylates BRF1 at Ser92, resulting in binding to 14-3-3 and impairment of mRNA decay activity. Here we identify an additional regulatory site at Ser203 that cooperates in vivo with Ser92. In vitro kinase labeling and wortmannin sensitivity indicate that Ser203 phosphorylation is also performed by PKB. Mutation of both serines to alanine uncouples BRF1 from PKB regulation, leading to constitutive mRNA decay even in the presence of stabilizing signals. BRF1 protein is labile because of proteasomal degradation (half-life, <3 h) but becomes stabilized upon phosphorylation and is less stable in PKBalpha(-/-) cells. Surprisingly, phosphorylation-dependent protein stability is also regulated by Ser92 and Ser203, with parallel phosphorylation required at these sites. Phosphorylation-dependent binding to 14-3-3 is abolished only when both sites are mutated. Cell compartment fractionation experiments support a model in which binding to 14-3-3 sequesters BRF1 through relocalization and prevents it from executing its mRNA decay activity, as well as from proteasomal degradation, thereby maintaining high BRF1 protein levels that are required to reinstate decay upon dissipation of the stabilizing signal.

Indexed as

AlanineAmino Acid SubstitutionAnimalsButyrate Response Factor 1Cell Line, TumorHumansMiceMice, KnockoutMutagenesis, Site-DirectedNIH 3T3 CellsNuclear ProteinsPhosphorylationProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, MessengerRNA StabilityAlanineButyrate Response Factor 1Nuclear ProteinsProto-Oncogene Proteins c-aktRNA-Binding ProteinsRNA, MessengerSerineTranscription Factor TFIIIBZfp36l1 protein, mouse

Identifiers

PMID17030608
PMCPMC1698544
OpenAlexW2162294478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.